PT  - JOURNAL ARTICLE
AU  - Haider, Zeeshan
AU  - Hussain, Sayed Sajid
TI  - PREVELANCE OF ISCHEMIC AND HEMORRAGHIC STROKE AMONG GERAITIC PATIENTS ADMITTED IN THE PUBLIC TERTIARY CARE HOSPITALS OF PESHAWAR
AID  - 10.1101/2023.03.30.23287970
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.03.30.23287970
4099  - http://medrxiv.org/content/early/2023/04/03/2023.03.30.23287970.short
4100  - http://medrxiv.org/content/early/2023/04/03/2023.03.30.23287970.full
AB  - Background Stroke is a life-threatening medical condition that can result in lifelong brain impairment, complications, and demise. Stroke is the world’s second biggest cause of mortality and could soon overtake as the biggest cause of death globally. It has 2 major pathological types’ i.e. ischemic stroke and hemorrhagic stroke. Hypertension, diabetes mellitus, cardiac diseases, smoking, physical inactivity and age are the risk factors that contribute in the occurrence of a stroke.Objective To find out the epidemiological status of stroke types among patients admitted in the public tertiary care hospitals of Peshawar.Methodology A descriptive cross-sectional study was carried out to determine the prevalence of stroke types in tertiary care hospitals of Peshawar. The sample size calculated for the research study was 109. Convenience sampling technique was used in this study.Results This study was performed among 109 research participants. The most affected were males as 51.13% and females were 45.87%.And the rate of ischemic stroke were 71% while that of hemorrhagic stroke were 28%.Conclusion the current research study concluded that majority of the patients had ischemic stroke as compared to the hemorrhagic stroke.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:After approval of Advance Studies and Research Board (ASRB), graduate committee and Ethical board of Sarhad University of Science and Information Technology the data was collected.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript